SA Transcripts 163.07K Followers
Acadia Pharmaceuticals Inc. (ACAD) UBS Global Biopharma Conference 2026 November 17, 2026 7:40 AM EST
Company Participants
Catherine Owen Adams - CEO & Director
Conference Call Participants
Ashwani Verma - UBS Investment Bank, Research Division
Presentation
Ashwani Verma
UBS Investment Bank, Research Division
Good day, everybody. My name is Ash Verma. I cover SMID-cap Biotech and Spec Pharma at UBS and really excited to host Acadia Pharmaceuticals. And for -- just to give a quick background, Acadia has DAYBUE and NUPLAZID, but I will just, like, pass it on to Catherine, like, if you can talk a little bit about the story in terms of where the focus of the growth opportunities is for both the products, and then you can talk about the pipeline and other things after that.
Catherine Owen Adams
CEO & Director
Sounds good. So we just delivered our quarter results.…